News Sentiment

NNNN sentiment intelligence

Anbio Biotechnology Class A Ordinary Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 44 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 9.39 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

86/100 classification confidence.

Company focus 44

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-26.1% over one week, -39.8% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Anbio Biotechnology Files Mixed Shelf Registration

Market Reaction

Price moving ahead of tone

67/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 86/100 classification
One-week reaction -26.1% Price reacting lower
Trend fit Trend inactive -39.8% over four weeks
Fair value -62.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 27
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 44
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 7
TipRanks 6
Defense World 6
TradingView 5
simplywall.st 2
MarketBeat 2
MT Newswires 1
Benzinga 1

Event Lens

What the news is about

Classified themes
Market update 32
Earnings 7
Analyst action 2
Balance sheet 1
Regulatory and legal 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-44 of 44
TipRanks Direct company coverage

Why Anbio Biotechnology’s Stock is Tumbling - TipRanks

Anbio Biotechnology Class A (NNNN) is experiencing significant stock volatility, including recent trading halts due to large price swings. The stock initially surged but has faced multiple declines, reflecting investor uncertainty and broader market conditions affecting its perce

Tone
Neutral 50/100
Event
Market update
Published
13 Oct 2025 16:24
Source
TipRanks
Stock Titan Direct company coverage

NNNN Stock Price, News & Analysis

Anbio Biotechnology (Nasdaq: NNNN) is a global in vitro diagnostics (IVD) company specializing in diagnostic products for human and veterinary health, utilizing five key platforms for biomarker detection. The company has a global presence across the EU, APAC, and the Americas, wi

Tone
Positive 67/100
Event
Market update
Published
28 Apr 2025 09:39
Source
Stock Titan
Simply Wall Street Direct company coverage

Anbio Biotechnology (NNNN) Company Information

This report provides comprehensive company information for Anbio Biotechnology (NNNN), detailing its market capitalization, employee growth, and exchange listings. It includes key data like the company's founding year, industry, sector, shares outstanding, and website. The report

Tone
Neutral 50/100
Event
Market update
Published
21 Feb 2025 10:08
Source
Simply Wall Street
Simply Wall St Direct company coverage

Anbio Biotechnology (NNNN) Leadership & Management Team Analysis

This article provides an analysis of Anbio Biotechnology's leadership and management team. It details information about CEO Michael Lau's compensation and tenure, along with an overview of the leadership team and board members. The report also includes recent management updates a

Tone
Neutral 50/100
Event
Market update
Published
21 Feb 2025 04:52
Source
Simply Wall St
GlobeNewswire Direct company coverage

Anbio Biotechnology Announces Closing of Initial Public Offering

Anbio Biotechnology has announced the closing of its initial public offering, raising gross proceeds of US$8 million from the sale of 1,600,000 Class A ordinary shares at US$5.00 each. The shares began trading on the Nasdaq Global Market under the ticker symbol "NNNN" on February

Tone
Positive 76/100
Event
Market update
Published
20 Feb 2025 12:40
Source
GlobeNewswire
Stock Titan Direct company coverage

NNNN - ANBIO BIOTECHNOLOGY Latest Stock News & Market Updates

This page provides the latest news and market updates for Anbio Biotechnology (NNNN), a global in vitro diagnostics company. It highlights recent product launches, such as the Chikungunya Rapid Test and the AP-100 Ultra-Fast PCR system, as well as the company's participation in i

Tone
Positive 66/100
Event
Market update
Published
20 Feb 2025 09:57
Source
Stock Titan
Nasdaq Direct company coverage

Anbio Biotechnology Closes Initial Public Offering, Raising $8 Million on Nasdaq

Anbio Biotechnology has successfully completed its initial public offering, raising $8 million by offering 1,600,000 Class A ordinary shares at $5.00 each. The shares commenced trading on Nasdaq under the ticker "NNNN" on February 19, 2025. The capital will be utilized for expand

Tone
Positive 65/100
Event
Market update
Published
20 Feb 2025 08:09
Source
Nasdaq